Assessment of mesalamine in the alterations of metabolic parameters in comorbid ulcerative colitis and metabolic syndrome patients: A retrospective study
Graziella R. Paniz, Fray M. Arroyo-Mercado, Christina L. Ling, E. Eunice Choi, Harry E. Snow, Neal E. Rakov, View ORCID ProfileEliseo F. Castillo
doi: https://doi.org/10.1101/2021.05.27.21257690
Graziella R. Paniz
1Division of Gastroenterology and Hepatology, Department of Internal Medicine, University of New Mexico Health Sciences Center, Albuquerque, NM 87131
Fray M. Arroyo-Mercado
1Division of Gastroenterology and Hepatology, Department of Internal Medicine, University of New Mexico Health Sciences Center, Albuquerque, NM 87131
Christina L. Ling
1Division of Gastroenterology and Hepatology, Department of Internal Medicine, University of New Mexico Health Sciences Center, Albuquerque, NM 87131
E. Eunice Choi
2Clinical and Translational Science Center, University of New Mexico Health Sciences Center, Albuquerque, NM 87131
Harry E. Snow
2Clinical and Translational Science Center, University of New Mexico Health Sciences Center, Albuquerque, NM 87131
Neal E. Rakov
1Division of Gastroenterology and Hepatology, Department of Internal Medicine, University of New Mexico Health Sciences Center, Albuquerque, NM 87131
Eliseo F. Castillo
1Division of Gastroenterology and Hepatology, Department of Internal Medicine, University of New Mexico Health Sciences Center, Albuquerque, NM 87131
2Clinical and Translational Science Center, University of New Mexico Health Sciences Center, Albuquerque, NM 87131
Data Availability
The datasets generated and analyzed during this study are not publicly available because of institutional review board restrictions, but data acquisition is described in methods.
Posted May 29, 2021.
Assessment of mesalamine in the alterations of metabolic parameters in comorbid ulcerative colitis and metabolic syndrome patients: A retrospective study
Graziella R. Paniz, Fray M. Arroyo-Mercado, Christina L. Ling, E. Eunice Choi, Harry E. Snow, Neal E. Rakov, Eliseo F. Castillo
medRxiv 2021.05.27.21257690; doi: https://doi.org/10.1101/2021.05.27.21257690
Assessment of mesalamine in the alterations of metabolic parameters in comorbid ulcerative colitis and metabolic syndrome patients: A retrospective study
Graziella R. Paniz, Fray M. Arroyo-Mercado, Christina L. Ling, E. Eunice Choi, Harry E. Snow, Neal E. Rakov, Eliseo F. Castillo
medRxiv 2021.05.27.21257690; doi: https://doi.org/10.1101/2021.05.27.21257690
Subject Areas
- Addiction Medicine (403)
- Allergy and Immunology (712)
- Anesthesia (206)
- Cardiovascular Medicine (2967)
- Dermatology (252)
- Emergency Medicine (445)
- Epidemiology (12803)
- Forensic Medicine (12)
- Gastroenterology (830)
- Genetic and Genomic Medicine (4617)
- Geriatric Medicine (423)
- Health Economics (732)
- Health Informatics (2941)
- Health Policy (1072)
- Hematology (393)
- HIV/AIDS (931)
- Medical Education (430)
- Medical Ethics (116)
- Nephrology (475)
- Neurology (4402)
- Nursing (238)
- Nutrition (648)
- Oncology (2292)
- Ophthalmology (651)
- Orthopedics (260)
- Otolaryngology (327)
- Pain Medicine (280)
- Palliative Medicine (84)
- Pathology (502)
- Pediatrics (1199)
- Primary Care Research (502)
- Public and Global Health (6996)
- Radiology and Imaging (1542)
- Respiratory Medicine (920)
- Rheumatology (444)
- Sports Medicine (386)
- Surgery (491)
- Toxicology (60)
- Transplantation (212)
- Urology (182)